Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.

Autor: Gan LT; Liver Research Group, Australian National University (ANU) Medical School at The Canberra Hospital, Garran, ACT, Australia., Van Rooyen DM; Liver Research Group, Australian National University (ANU) Medical School at The Canberra Hospital, Garran, ACT, Australia., Koina ME; Department of Anatomical Pathology, ACT Pathology, The Canberra Hospital, ACT, Australia., McCuskey RS; Department of Cellular and Molecular Medicine, College of Medicine, University of Arizona, USA., Teoh NC; Liver Research Group, Australian National University (ANU) Medical School at The Canberra Hospital, Garran, ACT, Australia., Farrell GC; Liver Research Group, Australian National University (ANU) Medical School at The Canberra Hospital, Garran, ACT, Australia. Electronic address: geoff.farrell@anu.edu.au.
Jazyk: angličtina
Zdroj: Journal of hepatology [J Hepatol] 2014 Dec; Vol. 61 (6), pp. 1376-84. Date of Electronic Publication: 2014 Jul 24.
DOI: 10.1016/j.jhep.2014.07.024
Abstrakt: Background & Aims: Free cholesterol (FC) accumulates in non-alcoholic steatohepatitis (NASH) but not in simple steatosis. We sought to establish how FC causes hepatocyte injury.
Methods: In NASH-affected livers from diabetic mice, subcellular FC distribution (filipin fluorescence) was established by subcellular marker co-localization. We loaded murine hepatocytes with FC by incubation with low-density lipoprotein (LDL) and studied the effects of FC on JNK1 activation, mitochondrial injury and cell death and on the amplifying roles of the high-mobility-group-box 1 (HMGB1) protein and the Toll-like receptor 4 (TLR4).
Results: In NASH, FC localized to hepatocyte plasma membrane, mitochondria and ER. This was reproduced in FC-loaded hepatocytes. At 40 μM LDL, hepatocyte FC increased to cause LDH leakage, apoptosis and necrosis associated with JNK1 activation (c-Jun phosphorylation), mitochondrial membrane pore transition, cytochrome c release, oxidative stress (GSSG:GSH ratio) and ATP depletion. Mitochondrial swelling and crystae disarray were evident by electron microscopy. Jnk1(-/-) and Tlr4(-/-) hepatocytes were refractory to FC lipotoxicity; JNK inhibitors (1-2 μM CC-401, CC-930) blocked apoptosis and necrosis. Cyclosporine A and caspase-3 inhibitors protected FC-loaded hepatocytes, confirming mitochondrial cell death pathways; in contrast, 4-phenylbutyric acid, which improves ER folding capacity did not protect FC-loaded hepatocytes. HMGB1 was released into the culture medium of FC-loaded wild type (WT) but not Jnk1(-/-) or Tlr4(-/-) hepatocytes, while anti-HMGB1 anti-serum prevented JNK activation and FC lipotoxicity in WT hepatocytes.
Conclusions: These novel findings show that mitochondrial FC deposition causes hepatocyte apoptosis and necrosis by activating JNK1; inhibition of which could be a novel therapeutic approach in NASH. Further, there is a tight link between JNK1-dependent HMGB1 secretion from lipotoxic hepatocytes and a paracrine cytolytic effect on neighbouring cholesterol-loaded hepatocytes operating via TLR4.
(Copyright © 2014. Published by Elsevier B.V.)
Databáze: MEDLINE